Treatment of ophthalmological conditions with acetylcholinesterase inhibitors Grant US-11446241-B2 United States of America 20 Sep 2022
Spinosyn formulations for treatment of Demodex-induced ocular and facial conditions Grant US-11254701-B2 United States of America 22 Feb 2022
Acetylcholinesterase inhibitors for treatment of dermatological conditions Grant US-11045442-B2 United States of America 29 Jun 2021
Spinosyn formulations for treatment of demodex-induced ocular and facial conditions Grant US-10730901-B2 United States of America 04 Aug 2020